140
Views
11
CrossRef citations to date
0
Altmetric
Original Research

Levodopa-Carbidopa Intestinal Gel Infusion Therapy Discontinuation: A Ten-Year Retrospective Analysis of 204 Treated Patients

, ORCID Icon, , ORCID Icon, , ORCID Icon, , ORCID Icon, , , ORCID Icon & ORCID Icon show all
Pages 1835-1844 | Published online: 28 Jul 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Viorelia A Constantin, József A Szász, Adriana Octaviana Dulamea, Peter Valkovic & Jaime Kulisevsky. (2023) Impact of Infusion Therapies on Quality of Life in Advanced Parkinson’s Disease. Neuropsychiatric Disease and Treatment 19, pages 1959-1972.
Read now

Articles from other publishers (10)

Pierluigi Lezzi, Roberto Lupo, Tania Lezzi & Elsa Vitale. (2022) The Prephase Nursing in Levodopa Carbidopa Intestinal Gel Therapy. Journal of Neuroscience Nursing 54:5, pages 215-219.
Crossref
Krisztina Kelemen, Attila Kövecsi, Laura Banias, Izolda Klára, István Mihály, Csilla Forró, József Attila Szász & Szabolcs Szatmári. (2022) A Rare Case of Histopathologically Confirmed Creutzfeldt–Jakob Disease from Romania, Long Route to Diagnosis—Case Report and an Overview of the Romanian CJD Situation. Journal of Clinical Medicine 11:16, pages 4803.
Crossref
József Attila Szász, Viorelia Adelina Constantin, Károly Orbán-Kis, Ligia Ariana Bancu, Simona Maria Bataga, Marius Ciorba, Előd Nagy, Mircea Radu Neagoe, István Mihály, Róbert Máté Szász, Krisztina Kelemen, Mihaela Simu & Szabolcs Szatmári. (2022) Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson’s Disease: Observations and Dilemmas after 10 Years of Real-Life Experience. Pharmaceutics 14:6, pages 1115.
Crossref
Avner Thaler, Yael Barer, Ruth Gross, Raanan Cohen, Lars Bergmann, Yash J. Jalundhwala, Nir Giladi, Gabriel Chodick, Varda Shalev & Tanya Gurevich. (2022) Long-Term Persistence and Monotherapy with Device-Aided Therapies: A Retrospective Analysis of an Israeli Cohort of Patients with Advanced Parkinson’s Disease. Advances in Therapy 39:5, pages 2009-2024.
Crossref
Mihaela Adriana Simu, Dragoș Cătălin Jianu, Adriana Octaviana Dulamea, Viorelia Adelina Constantin, Diana Popescu, Juan Carlos Parra & József Attila Szász. (2021) Advanced Parkinson’s Disease Treatment Simplification and Long-Term Outcomes with Levodopa Carbidopa Intestinal Gel: COSMOS Romanian Subanalysis. Brain Sciences 11:12, pages 1566.
Crossref
Taiji Tsunemi, Genko Oyama, Shinji Saiki, Taku Hatano, Jiro Fukae, Yasushi Shimo & Nobutaka Hattori. (2021) Intrajejunal Infusion of Levodopa/Carbidopa for Advanced Parkinson's Disease: A Systematic Review. Movement Disorders 36:8, pages 1759-1771.
Crossref
József Attila Szász, Viorelia Adelina Constantin, Károly Orbán-Kis, Ligia Ariana Bancu, Marius Ciorba, István Mihály, Előd Ernő Nagy, Róbert Máté Szász, Krisztina Kelemen, Mihaela Adriana Simu & Szabolcs Szatmári. (2021) Management Challenges of Severe, Complex Dyskinesia. Data from a Large Cohort of Patients Treated with Levodopa-Carbidopa Intestinal Gel for Advanced Parkinson’s Disease. Brain Sciences 11:7, pages 826.
Crossref
Elena Cecilia Rosca, Raluca Tudor, Amalia Cornea & Mihaela Simu. (2021) Parkinson’s Disease in Romania: A Scoping Review. Brain Sciences 11:6, pages 709.
Crossref
Mezin Öthman, Erik Widman, Ingela Nygren & Dag Nyholm. (2021) Initial Experience of the Levodopa–Entacapone–Carbidopa Intestinal Gel in Clinical Practice. Journal of Personalized Medicine 11:4, pages 254.
Crossref
Jozsef Attila Szasz, Dragos Catalin Jianu, Mihaela Adriana Simu, Viorelia Adelina Constantin, Adriana Octaviana Dulamea, Koray Onuk, Diana Popescu, Mihai-Titus Vasile, Bogdan Ovidiu Popescu, Alfonso Fasano & Ovidiu Alexandru Bajenaru. (2021) Characterizing Advanced Parkinson’s Disease: Romanian Subanalysis from the OBSERVE-PD Study. Parkinson's Disease 2021, pages 1-12.
Crossref